Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q9)Dec 31, 2022 | (Q6)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 74.68%67.22M | 60.81%99.22M | 10.66%38.48M | -21.09%61.7M | -18.81%34.78M | -9.66%16.85M | -18.47%78.19M | -13.90%62.88M | -11.72%42.83M | -28.97%18.65M |
| Operating income | 74.68%67.22M | 60.81%99.22M | 10.66%38.48M | -21.09%61.7M | -18.81%34.78M | -9.66%16.85M | -18.47%78.19M | -13.90%62.88M | -11.72%42.83M | -28.97%18.65M |
| Cost of sales | -172.14%-39.06M | -31.66%-30.43M | -26.02%-14.35M | 13.16%-23.11M | 22.13%-11.39M | 16.15%-5.23M | 17.85%-26.61M | 13.05%-20.75M | 7.00%-14.63M | 27.29%-6.24M |
| Operating expenses | -172.14%-39.06M | -31.66%-30.43M | -26.02%-14.35M | 13.16%-23.11M | 22.13%-11.39M | 16.15%-5.23M | 17.85%-26.61M | 13.05%-20.75M | 7.00%-14.63M | 27.29%-6.24M |
| Gross profit | 16.71%28.17M | 78.26%68.79M | 3.18%24.13M | -25.19%38.59M | -17.08%23.39M | -6.40%11.62M | -18.79%51.58M | -14.31%42.13M | -13.99%28.21M | -29.78%12.41M |
| Selling expenses | -5.59%-14.62M | 5.82%-28.62M | 11.74%-13.84M | 5.30%-30.39M | 12.92%-15.69M | 3.94%-8.5M | 3.92%-32.09M | -0.78%-26.7M | -4.15%-18.01M | -4.94%-8.84M |
| Administrative expenses | -5.36%-12.42M | -7.03%-25.62M | -2.31%-11.79M | -6.17%-23.94M | 7.59%-11.53M | 15.30%-5.04M | 15.79%-22.55M | -13.30%-17.8M | -14.08%-12.47M | -3.05%-5.95M |
| Revaluation surplus | ---- | ---293K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Changes in the fair value of financial assets | ---- | ---293K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | ---1.25M | 67.79%-2.9M | ---- | 37.47%-9M | ---12.04M | ---- | -3,609.02%-14.39M | ---- | ---- | ---- |
| -Goodwill impairment | ---- | ---- | ---- | 40.99%-8.69M | ---- | ---- | ---14.73M | ---- | ---- | ---- |
| -Other impairment is provision | ---1.25M | -859.60%-2.9M | ---- | -187.54%-302K | ---12.04M | ---- | -15.85%345K | ---- | ---- | ---- |
| Special items of operating profit | -34.53%1.23M | -36.59%4.6M | -48.47%1.87M | -20.03%7.25M | 0.08%3.63M | -5.21%1.55M | 1,175.67%9.07M | 923.35%5.13M | 240.34%3.63M | 38.72%1.63M |
| Operating profit | 199.18%1.1M | 191.29%15.96M | 103.01%368K | -108.85%-17.48M | -1,005.93%-12.23M | 50.26%-376K | -206.90%-8.37M | -63.07%2.76M | -76.03%1.35M | -116.28%-756K |
| Financing cost | 1.91%-360K | -34.98%-1.61M | 30.75%-367K | -49.56%-1.2M | -60.61%-530K | -39.06%-267K | 5.89%-799K | -32.40%-519K | -6.45%-330K | -4.92%-192K |
| Earning before tax | 74,000.00%741K | 176.81%14.35M | 100.01%1K | -103.69%-18.68M | -1,350.98%-12.76M | 32.17%-643K | -231.34%-9.17M | -68.36%2.24M | -80.83%1.02M | -121.25%-948K |
| Tax | 18.71%-708K | -4,046.25%-3.16M | ---871K | 109.47%80K | ---- | ---- | 51.74%-845K | 54.40%-487K | 35.48%-520K | ---- |
| After-tax profit from continuing operations | 103.79%33K | 160.16%11.19M | 93.18%-870K | -85.70%-18.6M | -2,652.00%-12.76M | 32.17%-643K | -291.47%-10.01M | -70.85%1.75M | -88.93%500K | -124.54%-948K |
| After-tax profit from non-continuing business | ---- | -824.66%-9.58M | ---585K | --1.32M | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 102.27%33K | 109.31%1.61M | 88.60%-1.46M | -72.50%-17.27M | -2,652.00%-12.76M | 32.17%-643K | -291.47%-10.01M | -70.85%1.75M | -88.93%500K | -124.54%-948K |
| Profit attributable to shareholders | 102.27%33K | 109.31%1.61M | 88.60%-1.46M | -72.50%-17.27M | -2,652.00%-12.76M | 32.17%-643K | -291.47%-10.01M | -70.85%1.75M | -88.93%500K | -124.54%-948K |
| Basic earnings per share | 0 | 109.09%0.001 | 88.89%-0.0009 | -74.60%-0.011 | -2,800.00%-0.0081 | 33.33%-0.0004 | -290.91%-0.0063 | -71.05%0.0011 | -89.66%0.0003 | -125.00%-0.0006 |
| Diluted earnings per share | 0 | 109.09%0.001 | 88.89%-0.0009 | -74.60%-0.011 | -2,800.00%-0.0081 | 33.33%-0.0004 | -290.91%-0.0063 | -71.05%0.0011 | -89.66%0.0003 | -125.00%-0.0006 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- | Grant Thornton (Hong Kong) Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.